Revium Rx RVRC
OTC RVRC
$1.43 +0.00 (+0.00%)
At close: Oct 20, 2026 · 4:00 PM EDT

Revium Rx (RVRC) Liabilities and Shareholders Equity (2024 - 2026)

Updated

Revium Rx's Liabilities and Shareholders Equity was $7.11 million in Q2 2026.

Analysis

Revium Rx (RVRC) Liabilities and Shareholders Equity (2024 - 2026) Analysis & Trends

At the end of FY2025, Liabilities and Shareholders Equity at Revium Rx came in at $8.3 million, down 59.1% from FY2024.

  • In earlier years, Liabilities and Shareholders Equity was $20.28 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 142.28 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 197.43 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 135.12 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 115.83 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 49.36 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 201.13 Bn
10 Revium Rx 86.84 Mn 86.00 Mn - 7.11 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.11 Mn
Dec 31, 2025 8.30 Mn
Dec 31, 2024 20.28 Mn
API Access

Revium Rx Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=RVRC&period=max&api_key=YOUR_API_KEY